Skip to content

Construction of artificial intelligence health management platform based on dysfunction of Shaoyang for the treatment of metabolic syndrome and prevention of ischemic cerebrovascular disease.

Construction of artificial intelligence health management platform based on dysfunction of Shaoyang for the treatment of metabolic syndrome and prevention of ischemic cerebrovascular disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032756
Enrollment
Unknown
Registered
2020-05-09
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome, ischemic cerebrovascular disease

Interventions

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In line with the diagnostic criteria of western medicine namely metabolic syndrome patients. 2. In accordance with the Chinese medicine shaoyang cardinal adverse syndrome of the patients, the age between 18 and 70 years old, men and women are not limited. 3. Informed consent, signed informed consent, and voluntary test.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Type 1 diabetes and gestational diabetes and other types of diabetes, secondary hypertension and/or hyperlipidemia; 3. There are serious complications such as heart, liver, kidney or other serious primary diseases associated with mental illness patients.

Design outcomes

Primary

MeasureTime frame
blood glucose;blood pressure;blood fat;Objective index of the four diagnosis of TCM;

Secondary

MeasureTime frame
Pulse wave velocity and ankle-brachial index were detected;

Countries

China

Contacts

Public ContactWang Bing

Shanghai Sixth People's Hospital

ebingliver@163.com+86 18930177667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026